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Welcome Letter 
The enormous importance of osteoarthritis as a major global health burden is just beginning to be 
recognized. Also, it is becoming apparent that osteoarthritis represents a major economic burden in terms of 
medical costs, costs of disability and loss of work hours due to absenteeism. In the highly developed nations, 
the recent economic growth has been fueled to a great extent by increased productivity. However, 
osteoarthritis is one of the diseases that can affect most seriously the growth in productivity of the world's 
economy. At the same time, it has become very apparent that the mechanisms responsible for the disease, 
as well as its effective treatment, are beyond our reach. The pathogenesis of osteoarthritis remains obscure 
despite the substantial scientific advances in the last decade and the application of state-of-the-art molecular 
and genetic approaches. Our knowledge of the cause of the disease is even less advanced. Without 
knowledge of the cause or a clear understanding of the pathogenesis, therapeutic approaches for 
osteoarthritis remain largely empirical. The current treatment for patients with osteoarthritis is to a large 
extent symptomatic and has not kept pace with the enormous therapeutic advances accomplished in the last 
decade for other diseases such as heart disease and cancer. The recent advances on our understanding of 
the structure and function of articular cartilage and of the complex molecular and intracellular pathways 
involved in its normal function have clearly opened up extraordinarily promising new possibilities. These 
advances will certainly be reflected immediately in the development of novel therapeutic agents. The last 
decade has also witnessed explosive progress in the molecular biology and genetics of various diseases, 
and has culminated with the extraordinary task of sequencing the entire human genome earlier this year. 
Thus, a new era of scientific investigation has begun with the application of genomics and proteomics, as 
well as with the more extensive use of gene microarray technology. These developments will undoubtedly be 
of enormous value in advancing our knowledge about the etiology and pathogenesis of osteoarthritis, and I 
am convinced that within the next decade we will witness extraordinary progress on the path to deciphering 
and solving these challenging puzzles. We will also witness the development of effective and novel therapies. 
The Fifth World Congress on Osteoarthritis will cover a wide spectrum of scientific issues bringing the most 
advanced knowledge about the topics mentioned above. The scientific program put together by the Scientific 
Program Committee has an extraordinary broadness in scope, while maintaining a keen depth of knowledge. 
In the program, the most recent advances in the areas of clinical and basic investigation related to 
osteoarthritis and cartilage will be presented and current and future therapeutic approaches discussed. 
On behalf of the Board of Directors of the Osteoarthritis Research Society international and of the 
members of the Scientific Committee, I welcome you all to Barcelona, Spain. I am convinced that you will 
enjoy and benefit enormously from the extraordinary scientific program that has been prepared for this 
Congress. 
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